Market Cap 525.12M
Revenue (ttm) 99.60M
Net Income (ttm) 8.55M
EPS (ttm) N/A
PE Ratio 40.69
Forward PE 36.17
Profit Margin 8.58%
Debt to Equity Ratio 0.00
Volume 791,800
Avg Vol 1,027,518
Day's Range N/A - N/A
Shares Out 79.81M
Stochastic %K 75%
Beta 2.31
Analysts Strong Sell
Price Target $15.25

Company Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient...

Industry: Biotechnology
Sector: Healthcare
Phone: 310 388 6706
Address:
10900 Wilshire Blvd, Suite 600, Los Angeles, United States
wycliff
wycliff Dec. 12 at 3:18 PM
$NAGE it wouldn’t be surprising that once the short covering occurs that those institutions who were short might even cover and go long!
0 · Reply
wycliff
wycliff Dec. 12 at 3:15 PM
$NAGE if we get some more insiders buying like Ozan Pamir that would also be a strong signal that the company management has high expectations for this company’s future success
0 · Reply
wycliff
wycliff Dec. 12 at 3:08 PM
$NAGE for those who do not know Watson’s is the largest beauty and health store in the world!Big in Asia and Singapore and actually owns stores in Europe under other chains with a different name
0 · Reply
wycliff
wycliff Dec. 12 at 3:05 PM
$NAGE recently was in HongKong and visited Watson’s Health and Beauty store and learned that they are actively promoting Tru-Niagen by encouraging customer’s to switch from NMN and actually had a special pricing deal for customers who have never bought Tru-Niagen.They told me th egg y actually can track whether someone is a first time buyer or not.!
0 · Reply
wycliff
wycliff Dec. 12 at 3:00 PM
$NAGE once tax loss selling ends in December the following might happen.If company continues to deliver on better than expected revenues and earnings as well as any positive clinical results shorts would be compelled to close out their http://positions.Company new stock buy announcement might even create a short squeeze.Keeping my hopes up for a great 2026
0 · Reply
wycliff
wycliff Dec. 12 at 2:31 AM
$NAGE https://www.truniagen.com/
0 · Reply
wycliff
wycliff Dec. 12 at 2:12 AM
$NAGE Tru Niagen: Still searching for the perfect gift? Optimize gift-giving with clinically studied NAD+ support for healthy aging for everyone on your list. https://kla6.io/5jrnNs Text STOP to opt-out
0 · Reply
Rainmaker64
Rainmaker64 Dec. 11 at 9:09 PM
$NAGE UPDATED Short Positions Nov 28, 2025 Short Interest: 5.52M Shares Float: 52.65M Avg. Daily Vol: 1.06M Short Float: 10.49% Short Ratio: 5.22
0 · Reply
Jimgym
Jimgym Dec. 11 at 7:47 PM
$NAGE search “life I/O baseline” on insta and FB, lots of reels posted. Seems clear that Herbalife has already cast a very wide net with nutrition/fitness influencers. Only funny thing is can’t seem to find an actual order page yet. Must be imminent.
0 · Reply
CarpSlayer
CarpSlayer Dec. 11 at 3:50 PM
$NAGE New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests Experimental medication boosts metabolism in muscles rather than suppressing appetite like GLP-1 drugs Published December 10, 2025 "Our results point to a future where we can improve metabolic health without losing muscle mass," said Tore Bengtsson, professor at the Department of Molecular Bioscience at Wenner-Gren Institute, Stockholm University, in the release. "Muscles are important in both type 2 diabetes and obesity, and muscle mass is also directly correlated with life expectancy." This is based on a Phase 1 Clinical Trial. "Looking ahead, the company that developed the drug, Atrogi AB, plans to conduct a larger phase 2 clinical trial with a larger, more diverse population, including people with obesity." https://www.foxnews.com/health/new-ozempic-alternative-diabetes-pill-burns-fat-without-muscle-loss-study-suggests
0 · Reply
Latest News on NAGE
Niagen Bioscience: High Conviction, High Expectations

Jun 11, 2025, 6:48 AM EDT - 6 months ago

Niagen Bioscience: High Conviction, High Expectations


Niagen Bioscience, Inc. (NAGE) Q1 202 Earnings Call Transcript

May 10, 2025, 1:40 PM EDT - 7 months ago

Niagen Bioscience, Inc. (NAGE) Q1 202 Earnings Call Transcript


ChromaDex to Present at the 37th Annual Roth Conference

Mar 11, 2025, 4:04 PM EDT - 9 months ago

ChromaDex to Present at the 37th Annual Roth Conference


ChromaDex Capitalizes On Longevity Boom But Valuation Remains High

Mar 6, 2025, 10:30 AM EST - 10 months ago

ChromaDex Capitalizes On Longevity Boom But Valuation Remains High


ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 8:53 PM EST - 10 months ago

ChromaDex Corporation (CDXC) Q4 2024 Earnings Call Transcript


ChromaDex Appoints Ozan Pamir as Chief Financial Officer

Sep 20, 2024, 8:32 AM EDT - 1 year ago

ChromaDex Appoints Ozan Pamir as Chief Financial Officer


wycliff
wycliff Dec. 12 at 3:18 PM
$NAGE it wouldn’t be surprising that once the short covering occurs that those institutions who were short might even cover and go long!
0 · Reply
wycliff
wycliff Dec. 12 at 3:15 PM
$NAGE if we get some more insiders buying like Ozan Pamir that would also be a strong signal that the company management has high expectations for this company’s future success
0 · Reply
wycliff
wycliff Dec. 12 at 3:08 PM
$NAGE for those who do not know Watson’s is the largest beauty and health store in the world!Big in Asia and Singapore and actually owns stores in Europe under other chains with a different name
0 · Reply
wycliff
wycliff Dec. 12 at 3:05 PM
$NAGE recently was in HongKong and visited Watson’s Health and Beauty store and learned that they are actively promoting Tru-Niagen by encouraging customer’s to switch from NMN and actually had a special pricing deal for customers who have never bought Tru-Niagen.They told me th egg y actually can track whether someone is a first time buyer or not.!
0 · Reply
wycliff
wycliff Dec. 12 at 3:00 PM
$NAGE once tax loss selling ends in December the following might happen.If company continues to deliver on better than expected revenues and earnings as well as any positive clinical results shorts would be compelled to close out their http://positions.Company new stock buy announcement might even create a short squeeze.Keeping my hopes up for a great 2026
0 · Reply
wycliff
wycliff Dec. 12 at 2:31 AM
$NAGE https://www.truniagen.com/
0 · Reply
wycliff
wycliff Dec. 12 at 2:12 AM
$NAGE Tru Niagen: Still searching for the perfect gift? Optimize gift-giving with clinically studied NAD+ support for healthy aging for everyone on your list. https://kla6.io/5jrnNs Text STOP to opt-out
0 · Reply
Rainmaker64
Rainmaker64 Dec. 11 at 9:09 PM
$NAGE UPDATED Short Positions Nov 28, 2025 Short Interest: 5.52M Shares Float: 52.65M Avg. Daily Vol: 1.06M Short Float: 10.49% Short Ratio: 5.22
0 · Reply
Jimgym
Jimgym Dec. 11 at 7:47 PM
$NAGE search “life I/O baseline” on insta and FB, lots of reels posted. Seems clear that Herbalife has already cast a very wide net with nutrition/fitness influencers. Only funny thing is can’t seem to find an actual order page yet. Must be imminent.
0 · Reply
CarpSlayer
CarpSlayer Dec. 11 at 3:50 PM
$NAGE New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests Experimental medication boosts metabolism in muscles rather than suppressing appetite like GLP-1 drugs Published December 10, 2025 "Our results point to a future where we can improve metabolic health without losing muscle mass," said Tore Bengtsson, professor at the Department of Molecular Bioscience at Wenner-Gren Institute, Stockholm University, in the release. "Muscles are important in both type 2 diabetes and obesity, and muscle mass is also directly correlated with life expectancy." This is based on a Phase 1 Clinical Trial. "Looking ahead, the company that developed the drug, Atrogi AB, plans to conduct a larger phase 2 clinical trial with a larger, more diverse population, including people with obesity." https://www.foxnews.com/health/new-ozempic-alternative-diabetes-pill-burns-fat-without-muscle-loss-study-suggests
0 · Reply
wycliff
wycliff Dec. 11 at 2:28 PM
$NAGE https://www.linkedin.com/posts/niagenbioscience_nobellaureate-rogerkornberg-hkust-activity-7397670398638800896-uSzG?utm_source=share&utm_medium=member_ios&rcm=ACoAAAUGerIBOiyuZoO-6U9HRKRzZ48AD8YnjZA
0 · Reply
CarpSlayer
CarpSlayer Dec. 10 at 4:43 PM
$NAGE Dec 9, 2025 In The News FDA Classifies NAD+ Injection Recalls: Understanding the Safety Risks and What You Need to Know About Endotoxins and Quality https://www.aboutnad.com/blogs/blog/fda-classifies-nad-injection-recalls-understanding-the-safety-risks-and-what-you-need-to-know-about-endotoxins-and-quality
0 · Reply
wycliff
wycliff Dec. 10 at 1:17 PM
$NAGE https://www.instagram.com/p/DR94mQ-EcTs/?img_index=6&igsh=N3VzMDFwcHA2MzNq
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 10 at 1:22 AM
$NAGE Share Price: $6.52 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $0.38 – $0.47 Target Zone: $0.72 – $0.89 Potential Upside: 79% ROI Time to Expiration: 156 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
okeydokey_artichokey
okeydokey_artichokey Dec. 9 at 8:14 PM
$NAGE The mindshare that NMN still has in the gen pop. is surprising (came up in a Christmas gathering) . Will a positive NOPARK change that? I'd like to think "yes" ,but am doubtful reliance on solid clinical results will move the needle. At some point they're gonna have to change things. jmho - again, I welcome other opinions and mockery.
2 · Reply
Jimgym
Jimgym Dec. 9 at 6:09 PM
$NAGE Christiano Ronaldo partnered with Pro2Col https://www.instagram.com/reel/DHJE5SeyWmu/?l=1
0 · Reply
CarpSlayer
CarpSlayer Dec. 9 at 12:57 PM
$NAGE The Norwegian Parkinson Association, in collaboration with the Innlandet Parkinson Association, has invited Professor Tzoulis to give a lecture on research into Parkinson's disease. December 15, 2025 https://parkinson.no/tilbud-og-aktiviteter/kurs-og-arrangementer/velkommen-til-%C3%A5pent-m%C3%B8te
0 · Reply
Jimgym
Jimgym Dec. 9 at 12:59 AM
$NAGE Herbalife baseline IO video https://video.herbalife.com/detail/video/6385987929112/life-i-o-baseline:-know-the-products
1 · Reply
okeydokey_artichokey
okeydokey_artichokey Dec. 8 at 5:34 PM
$NAGE this is a really sweet clinical result. ill add that this points to use in allo- CAR-T therapy, which has many issues with maintaining metabolic state throughout procedure. more Tmem than Teff at time of transfusion. https://www.sciencedirect.com/science/article/pii/S0006497125051845
0 · Reply
wycliff
wycliff Dec. 8 at 1:15 PM
$NAGE https://www.niagenplus.com/blogs/blog/behind-the-science-an-interview-with-dr-rachele-pojednic-on-niagen-iv-therapy-at-restore
0 · Reply
MattManzanita
MattManzanita Dec. 7 at 9:27 PM
$NAGE I have seen speculation that Niagen Bio itself would have to await the peer review and publication of NoPark's data before seeing the results. I think most of us have assumed that Niagen Bio is seeing the data as it accumulates, but not disclosing it. The following from "Investing.com" indicates that Niagen Bio has access to the data. Based on the expressed interest in NoPark by the company, I think we. can assume that the resuklts are favorable: "Central to the agreement is access to data from the NOPARK trial (by Niagen Bioscience - my addition) , a recently completed phase III clinical study involving 400 individuals with early-stage Parkinson’s Disease across 12 Norwegian sites. The double-blind, placebo-controlled trial evaluated 500 mg of nicotinamide riboside twice daily versus placebo over 52 weeks, with results expected to be published by the end of 2025." We now expect the results early in 2026.
0 · Reply
wycliff
wycliff Dec. 7 at 4:54 AM
$NAGE https://www.supplysidesj.com/healthy-living/herbalife-says-acquisitions-new-products-will-revive-revenues
0 · Reply